MedPath

hydrocortisone and acetic acid

Hydrocortisone and Acetic Acid Otic Solution, USPRx only

Approved
Approval ID

d9a3597c-2c9d-46cc-818b-8bb3aa5c4f32

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 16, 2024

Manufacturers
FDA

Saptalis Pharmaceuticals, LLC

DUNS: 080145868

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

hydrocortisone and acetic acid otic

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code71656-064
Application NumberNDA012770
Product Classification
M
Marketing Category
C73594
G
Generic Name
hydrocortisone and acetic acid otic
Product Specifications
Route of AdministrationAURICULAR (OTIC)
Effective DateJanuary 16, 2024
FDA Product Classification

INGREDIENTS (7)

BENZETHONIUM CHLORIDEInactive
Code: PH41D05744
Classification: IACT
SODIUM ACETATEInactive
Code: 4550K0SC9B
Classification: IACT
ACETIC ACIDActive
Quantity: 20.75 mg in 1 mL
Code: Q40Q9N063P
Classification: ACTIB
HYDROCORTISONEActive
Quantity: 10.375 mg in 1 mL
Code: WI4X0X7BPJ
Classification: ACTIB
ANHYDROUS CITRIC ACIDInactive
Code: XF417D3PSL
Classification: IACT
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3
Classification: IACT
PROPYLENE GLYCOL DIACETATEInactive
Code: 5Z492UNF9O
Classification: IACT

Drug Labeling Information

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

LOINC: 51945-4Updated: 1/16/2024

PACKAGE/LABEL PRINCIPAL DISPLAY PANEL

NDC 71656-064-10

Hydrocortisone and Acetic Acid Otic Solution, USP

1% / 2%

For Otic Use Only.

Rx only

10 mL

Carton

INDICATIONS & USAGE SECTION

LOINC: 34067-9Updated: 1/12/2024

INDICATIONS AND USAGE: For the treatment of superficial infections of the external auditory canal caused by organisms susceptible to the action of the antimicrobial, complicated by inflammation.

CONTRAINDICATIONS SECTION

LOINC: 34070-3Updated: 1/12/2024

CONTRAINDICATIONS: Hypersensitivity to Hydrocortisone and Acetic Acid or any of the ingredients; herpes simplex, vaccinia and varicella. Perforated tympanic membrane is considered a contraindication to the use of any medication in the external ear canal.

ADVERSE REACTIONS SECTION

LOINC: 34084-4Updated: 1/12/2024

ADVERSE REACTIONS: Stinging or burning may be noted occasionally; local irritation has occurred very rarely.

To report SUSPECTED ADVERSE REACTIONS, contact Saptalis Pharmaceuticals, LLC at 1-833-727-8254 or FDA at 1-­800-FDA-1088 orwww.fda.gov/medwatch.

CLINICAL PHARMACOLOGY SECTION

LOINC: 34090-1Updated: 1/12/2024

CLINICAL PHARMACOLOGY: Acetic acid is antibacterial and antifungal; hydrocortisone is antiinflammatory, antiallergic and antipruritic; propylene glycol is hydrophilic and provides a low surface tension; benzethonium chloride is a surface active agent that promotes contact of the solution with tissues.

DESCRIPTION SECTION

LOINC: 34089-3Updated: 1/12/2024

DESCRIPTION: Hydrocortisone and Acetic Acid Otic Solution, USP is a solution containing hydrocortisone (1%) and acetic acid (2%), in a propylene glycol vehicle containing benzethonium chloride (0.02%), citric acid (0.05%), propylene glycol diacetate (3%) and sodium acetate (0.015%). The empirical formulas for acetic acid and hydrocortisone are CH3COOH, and C21H30O5, with a molecular weight of 60.05 and 362.46, respectively. The structural formulas are:

Chemical Structure_Hydrocortisone

Hydrocortisone and Acetic Acid is available as a nonaqueous otic solution buffered at pH 3 for use in the external ear canal.

WARNINGS SECTION

LOINC: 34071-1Updated: 1/12/2024

WARNINGS: Discontinue promptly if sensitization or irritation occurs.

SPL UNCLASSIFIED SECTION

LOINC: 42229-5Updated: 1/16/2024

STORAGE: Store at room temperature, 20° to 25°C (68° to 77°F). Keep container tightly closed.

Rx only

Distributed by:
Saptalis Pharmaceuticals, LLC
Hauppauge, NY 11788

MADE IN USA

January 2024-R2
PPM-0082

HOW SUPPLIED SECTION

LOINC: 34069-5Updated: 1/12/2024

HOW SUPPLIED: Hydrocortisone and Acetic Acid Otic Solution, USP, containing hydrocortisone (1%) and acetic acid (2%), is available in 10 mL, measured-drop, safety-tip plastic bottles (NDC 71656-064-10).

DOSAGE & ADMINISTRATION SECTION

LOINC: 34068-7Updated: 1/12/2024

DOSAGE AND ADMINISTRATION: Carefully remove all cerumen and debris to allow Hydrocortisone and Acetic Acid to contact infected surfaces directly. To promote continuous contact, insert a wick of cotton saturated with Hydrocortisone and Acetic Acid into the ear canal; the wick may also be saturated after insertion. Instruct the patient to keep the wick in for at least 24 hours and to keep it moist by adding 3 to 5 drops of Hydrocortisone and Acetic Acid every 4 to 6 hours. The wick may be removed after 24 hours but the patient should continue to instill 5 drops of Hydrocortisone and Acetic Acid 3 or 4 times daily thereafter, for as long as indicated. In pediatric patients, 3 to 4 drops may be sufficient due to the smaller capacity of the ear canal.

PRECAUTIONS SECTION

LOINC: 42232-9Updated: 1/12/2024

PRECAUTIONS: Transient stinging or burning may be noted occasionally when the solution is first instilled into the acutely inflamed ear.

PEDIATRIC USE: Safety and effectiveness in pediatric patients below the age of 3 years have not been established.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

hydrocortisone and acetic acid - FDA Drug Approval Details